| Literature DB >> 30174305 |
Marion Curtis1, Hilary A Kenny1, Bradley Ashcroft1, Abir Mukherjee1, Alyssa Johnson1, Yilin Zhang1, Ynes Helou2, Raquel Batlle3, Xiaojing Liu4, Nuria Gutierrez3, Xia Gao4, S Diane Yamada1, Ricardo Lastra5, Anthony Montag5, Nagib Ahsan6, Jason W Locasale4, Arthur R Salomon7, Angel R Nebreda8, Ernst Lengyel9.
Abstract
Successful metastasis requires the co-evolution of stromal and cancer cells. We used stable isotope labeling of amino acids in cell culture coupled with quantitative, label-free phosphoproteomics to study the bidirectional signaling in ovarian cancer cells and human-derived, cancer-associated fibroblasts (CAFs) after co-culture. In cancer cells, the interaction with CAFs supported glycogenolysis under normoxic conditions and induced phosphorylation and activation of phosphoglucomutase 1, an enzyme involved in glycogen metabolism. Glycogen was funneled into glycolysis, leading to increased proliferation, invasion, and metastasis of cancer cells co-cultured with human CAFs. Glycogen mobilization in cancer cells was dependent on p38α MAPK activation in CAFs. In vivo, deletion of p38α in CAFs and glycogen phosphorylase inhibition in cancer cells reduced metastasis, suggesting that glycogen is an energy source used by cancer cells to facilitate metastatic tumor growth.Entities:
Keywords: PGM1; cancer-associated fibroblast; glycogen; glycogen phosphorylase; metabolism; metastasis; omentum; ovarian cancer; p38-MAPK; phosphoproteomics
Mesh:
Substances:
Year: 2018 PMID: 30174305 PMCID: PMC6326875 DOI: 10.1016/j.cmet.2018.08.007
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287